Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance. | Egypt Heart J | 2023 | 37014444 | PubTator, text mining | PubMed |
| A novel inflammation-related signature for predicting prognosis and characterizing the tumor microenvironment in colorectal cancer. | Aging (Albany NY) | 2023 | 37014331 | PubTator, text mining | PubMed |
| Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor. | Commun Biol | 2023 | 37012403 | PubTator, text mining | PubMed |
| Orange juice intake and lipid profile: a systematic review and meta-analysis of randomised controlled trials. | J Nutr Sci | 2023 | 37008412 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and mechanisms in foam cell formation from heterogeneous cellular origins via integrated transcriptome analysis. | Ann Transl Med | 2023 | 37007574 | PubTator, text mining | PubMed |
| Methylglyoxal: a novel upstream regulator of DNA methylation. | J Exp Clin Cancer Res | 2023 | 36998085 | PubTator, text mining | PubMed |
| Ketones and the Heart: Metabolic Principles and Therapeutic Implications. | Circ Res | 2023 | 36996176 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity. | Viruses | 2023 | 36992348 | PubTator, text mining | PubMed |
| Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma-A Review. | Vaccines (Basel) | 2023 | 36992219 | PubTator, text mining | PubMed |
| An integrated multi-omic approach demonstrates distinct molecular signatures between human obesity with and without metabolic complications: a case-control study. | J Transl Med | 2023 | 36991398 | PubTator, text mining | PubMed |
| Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy. | Metabolites | 2023 | 36984809 | PubTator, text mining | PubMed |
| ACAT1/SOAT1 Blockade Suppresses LPS-Mediated Neuroinflammation by Modulating the Fate of Toll-like Receptor 4 in Microglia. | Int J Mol Sci | 2023 | 36982689 | PubTator, text mining | PubMed |
| Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. | Int J Mol Sci | 2023 | 36982602 | PubTator, text mining | PubMed |
| Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection. | Cells | 2023 | 36980194 | PubTator, text mining | PubMed |
| A Perspective on the Link between Mitochondria-Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases. | Biology (Basel) | 2023 | 36979106 | PubTator, text mining | PubMed |
| The construction and analysis of tricarboxylic acid cycle related prognostic model for cervical cancer. | Front Genet | 2023 | 36968582 | PubTator, text mining | PubMed |
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
| The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer's disease and the potential countermeasure. | Front Neurosci | 2023 | 36960176 | PubTator, text mining | PubMed |
| DNA methylation patterns at birth predict health outcomes in young adults born very low birthweight. | Clin Epigenetics | 2023 | 36959629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=20